Abstract
Earlier this year, investigators from the Mayo Clinic and Mayo Foundation in the US found a link between concomitant use of fenfluramine and phentermine, and valvular heart disease. This followed hot on the heels of news of a link between fenfluramines and primary pulmonary hypertension. A similar link was found with the anorectic agent aminorex almost 3 decades ago and led to market withdrawal of the agent. Despite this disturbing trend, many investigators maintain that the benefits of anorectic agents outweigh the potential risks; however, others disagree.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
